The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed ...

Roche is stopping patients on the low dose of its experimental Huntington’s drug tominersen, and will be transitioning them ...

US brand-name drugs use foreign ingredients, with Europe supplying 43% of APIs, as Trump administration considers 25% tariffs ...

Walgreens to go private via Sycamore Partners deal at $11.45/share after talks began in Feb 2024. Deal impacted by $595M Everly Health settlement. Expected to close Q4 2024.

Sanofi is teaming up with a private biotech in Delaware on a pair of bispecific antibodies for autoimmune and inflammatory ...

Bayer opens $44M expansion, Meribel Pharma launches, Ginkgo gets $29M contract, plus partnerships for Chime, Atelerix, ...

UnitedHealth Group reported disappointing first-quarter earnings and cut its financial guidance, hit by high costs in its ...

The Dutch government is committing €1.3 billion ($1.5 billion) to support biotech as part of a broader raft of measures ...

Jacob Elkins has left Sarepta to take the CMO job at AIRNA, the RNA editing shop that disclosed a $155 million Series ...

Eli Lilly reported the first Phase 3 data for its oral GLP-1 orforglipron Thursday morning, saying the drug succeeded in a ...

The London biotech Charm Therapeutics is looking for a new top executive to replace founding CEO Laksh Aithani, Endpoints ...

A CDC advisory panel voted to recommend RSV vaccines for at-risk adults 50 to 59, a sought-after expansion by vaccine makers ...